At a glance
ClinicalIndex Comparison RecordN/ACompleted· 597 enrolled
Drug / intervention
CanGaroo Envelope +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Experience of CIED Implantation With Piedmont Athens Regional Electrophysiology
In Brief
An observational study evaluating CanGaroo Envelope and TYRX Envelope for Cardiac Disease and 2 related conditions. Completed, enrolled 597 participants across 1 site.
Detailed Summary
The objective of this study is to retrospectively gather information on patients who underwent a CIED procedure with either a CanGaroo Envelope, TYRX Envelope, or no envelope.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Disease, Heart Failure, Coronary Artery Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartApr 2020
Primary CompletionJun 2021
TodayJul 2026
First PostedApr 17, 2020
Enrollment StartApr 22, 2020
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.2 years ago
Interventions
CanGaroo Envelopedevice
CanGaroo Envelope with Cardiac Implantable Electronic Device (CIED) implantation
TYRX Envelopedevice
TYRX Envelope with Cardiac Implantable Electronic Device (CIED) implantation